Myriad Genetics Shares Up 46.2% Since SmarTrend's Buy Recommendation (MYGN)

SmarTrend identified an Uptrend for Myriad Genetics (NASDAQ:MYGN) on May 8th, 2018 at $31.65. In approximately 4 months, Myriad Genetics has returned 46.22% as of today's recent price of...